Psychiatry

Top Story

Adverse childhood events likely to be passed in generations, are root of many chronic conditions

June 23, 2017

PHILADELPHIA —  Screening for adverse childhood events, such as child abuse or household dysfunction, in adults within a primary care setting may identify who is likely to pass along the same adverse events to their children especially mothers according to a recent presentation at the annual meeting of the American Association of Nurse Practitioners.

This process is especially important because children who experience adverse childhood events (ACEs) have a difficult time with memory, emotion regulation, attention and building relationships because of impaired neurodevelopment. A direct correlation has also been noted with an increased chance of health-risk behaviors in adulthood that heighten the risk of sexually transmitted infections (STIs), depression, obesity or smoking. Additionally, exposure to these events in childhood increases the risk for stroke, cancer, diabetes and other chronic conditions.

In the Journals

Suicide risk increases following hospital discharge for injury

June 22, 2017
Adolescents discharged from the hospital after adversity-related injury, including self-inflicted, drug- or alcohol-related, or violent injury, had significantly higher…
In the Journals

Microvascular dysfunction may increase risk for late-life depression

June 22, 2017
Peripheral and cerebral forms of microvascular dysfunction were associated with increased risk for depression, according to recent findings. “Evidence suggests a…
Meeting News

PTSD common in patients with familial adenomatous polyposis

June 22, 2017
Posttraumatic stress disorder is common among patients with familial adenomatous polyposis, for whom medical trauma from surgery could have been a trigger, according to…
Meeting News

Adverse childhood events likely to be passed in generations, are root of many chronic conditions

June 23, 2017
PHILADELPHIA —  Screening for adverse childhood events, such as child abuse or household dysfunction, in adults within a primary care…

In the Journals

Suicide risk increases following hospital discharge for injury

June 22, 2017
Adolescents discharged from the hospital after adversity-related injury, including self-inflicted, drug- or alcohol-related, or violent injury, had…

In the Journals

Microvascular dysfunction may increase risk for late-life depression

June 22, 2017
Peripheral and cerebral forms of microvascular dysfunction were associated with increased risk for depression, according to recent findings…

Meeting News

PTSD common in patients with familial adenomatous polyposis

June 22, 2017
Posttraumatic stress disorder is common among patients with familial adenomatous polyposis, for whom medical trauma from surgery could have been a…

In the Journals

Internet, in-person cognitive behavioral therapy effective for insomnia in military

June 22, 2017
Cognitive behavioral therapy for insomnia delivered in person or via the internet improved insomnia among military personnel. “About 10% of…

FDA News

FDA approves Mydayis for ADHD in adolescents

June 21, 2017
The FDA recently approved Mydayis, a once-daily mixed salts of a single-entity amphetamine product from Shire, for treatment of ADHD in individuals…

In the Journals

Comorbid ADHD, conduct disorder explains link between autism, violence

June 21, 2017
Autism was associated with an increased risk for violent crime; however, the association was significantly attenuated by comorbid ADHD or conduct…

Gut microbiome therapies show promise for treating autism

June 20, 2017
Therapies that target the gut microbiome through diet, prebiotics, probiotics, antibiotics or fecal microbiota transplantation could effectively…

Q&A: Treating patients with Alzheimer’s and their caregivers

June 20, 2017
Alzheimer’s and Brain Awareness Month is annually observed in June to raise awareness for the disease that currently affects more than 5…

FDA News

FDA approves disintegrating Cotempla tablet for ADHD

June 20, 2017
Neos Therapeutics Inc. recently announced the FDA approved Cotempla XR-ODT, an extended-release orally disintegrating tablet, for the treatment of…

More Headlines »
Advertisement
Advertisement